Welcome
Support Centre
11 February 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Fluorodeoxyglucose-positron emission tomography for avoidance of futile direct laryngoscopies under general anaesthesia with taking of biopsies in patients with suspicion on recurrent laryngeal carcinoma after radiotherapy
ISRCTN ISRCTN89530459
ClinicalTrials.gov identifier
Public title Fluorodeoxyglucose-positron emission tomography for avoidance of futile direct laryngoscopies under general anaesthesia with taking of biopsies in patients with suspicion on recurrent laryngeal carcinoma after radiotherapy
Scientific title
Acronym RELAPS: REcurrent LAryngeal carcinoma PET Study
Serial number at source ZonMw: 945-04-311 2004/036 (projectnummer VUmc); NTR93
Study hypothesis Not provided at time of registration
Lay summary
Ethics approval Ethics approval received from the local medical ethics committee
Study design Randomised, active controlled, parallel group trial
Countries of recruitment Netherlands
Disease/condition/study domain Laryngeal carcinoma
Participants - inclusion criteria 1. Patients with clinical suspicion on recurrent laryngeal carcinoma after radiotherapy (without obvious signs of tumour), in whom a direct laryngoscopy under general anaesthesia with taking of biopsies is indicated
2. T2 - T4 laryngeal carcinoma
Participants - exclusion criteria 1. Aged less than 18 years
2. Pregnancy
3. Radiotherapy within the last four months
Anticipated start date 01/02/2005
Anticipated end date 30/06/2007
Status of trial Completed
Patient information material
Target number of participants 150
Interventions Selection for direct laryngoscopy with fluorodeoxyglucose-positron emission tomography (FDG-PET). Two strategy arms are compared:
1. Conventional strategy: direct laryngoscopy under general anaesthesia with taking of biopsies
2. PET based strategy: only direct laryngoscopy under general anaesthesia with taking of biopsies if FDG-PET is positive or equivocal
Primary outcome measure(s) Number of direct laryngoscopies (on a group level) needed to detect (a single) recurrent laryngeal carcinoma.
Secondary outcome measure(s) Key:
1. Costs
2. Operability of a recurrence
3. Surgical margins of the salvage laryngectomy
4. Quality of life
Sources of funding The Netherlands Organisation for Health Research and Development (ZonMw) (The Netherlands)
Trial website
Publications
Contact name Dr  R  de Bree
  Address Boelelaan 1117
Department of Otolaryngology /Head and Neck Surgery
Vrije University Medical Centre
  City/town Amsterdam
  Zip/Postcode 1081 HV
  Country Netherlands
  Tel +31 (0)20 444 3690
  Fax +31 (0)20 444 3688
  Email r.bree@vumc.nl
Sponsor Vrije University Medical Centre (VUMC) (The Netherlands)
  Address Van der Boechorststraat 7
  City/town Amsterdam
  Zip/Postcode 1081 BT
  Country Netherlands
  Sponsor website: http://www.vumc.nl/english/
Date applied 12/09/2005
Last edited 19/09/2008
Date ISRCTN assigned 12/09/2005
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central